Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Pediatrics. 2012 Sep;130(3):e561-7. doi: 10.1542/peds.2011-3029. Epub 2012 Aug 20.
Observational studies suggest that serum levels of 25-hydroxyvitamin D (25[OH]D) are inversely associated with acute respiratory infections (ARIs). We hypothesized that vitamin D supplementation of children with vitamin D deficiency would lower the risk of ARIs.
By using cluster randomization, classrooms of 744 Mongolian schoolchildren were randomly assigned to different treatments in winter (January-March). This analysis focused on a subset of 247 children who were assigned to daily ingestion of unfortified regular milk (control; n = 104) or milk fortified with 300 IU of vitamin D(3) (n = 143). This comparison was double-blinded. The primary outcome was the number of parent-reported ARIs over the past 3 months.
At baseline, the median serum 25(OH)D level was 7 ng/mL (interquartile range: 5-10 ng/mL). At the end of the trial, follow-up was 99% (n = 244), and the median 25(OH)D levels of children in the control versus vitamin D groups was significantly different (7 vs 19 ng/mL; P < .001). Compared with controls, children receiving vitamin D reported significantly fewer ARIs during the study period (mean: 0.80 vs 0.45; P = .047), with a rate ratio of 0.52 (95% confidence interval: 0.31-0.89). Adjusting for age, gender, and history of wheezing, vitamin D continued to halve the risk of ARI (rate ratio: 0.50 [95% confidence interval: 0.28-0.88]). Similar results were found among children either below or above the median 25(OH)D level at baseline (rate ratio: 0.41 vs 0.57; P(interaction) = .27).
Vitamin D supplementation significantly reduced the risk of ARIs in winter among Mongolian children with vitamin D deficiency.
观察性研究表明,血清 25-羟维生素 D(25[OH]D)水平与急性呼吸道感染(ARI)呈负相关。我们假设维生素 D 缺乏症患儿补充维生素 D 会降低 ARI 的风险。
通过使用集群随机化,744 名蒙古学童的教室在冬季(1 月至 3 月)被随机分配到不同的治疗组。本分析集中于 247 名被分配到每日摄入未经强化的普通牛奶(对照组;n = 104)或强化 300IU 维生素 D(3)的牛奶(n = 143)的儿童子集。这种比较是双盲的。主要结局是过去 3 个月内父母报告的 ARI 数量。
在基线时,血清 25(OH)D 水平的中位数为 7ng/mL(四分位距:5-10ng/mL)。在试验结束时,随访率为 99%(n = 244),对照组和维生素 D 组儿童的中位数 25(OH)D 水平差异显著(7 vs 19ng/mL;P<.001)。与对照组相比,接受维生素 D 的儿童在研究期间报告的 ARI 明显较少(平均值:0.80 与 0.45;P =.047),发生率比为 0.52(95%置信区间:0.31-0.89)。调整年龄、性别和喘息史后,维生素 D 仍将 ARI 的风险减半(发生率比:0.50[95%置信区间:0.28-0.88])。在基线时血清 25(OH)D 水平低于或高于中位数的儿童中也发现了类似的结果(发生率比:0.41 与 0.57;P(交互)=.27)。
维生素 D 补充剂显著降低了蒙古维生素 D 缺乏症儿童冬季 ARI 的风险。